Major depressive disorder | OR (CI 95%) | Test of significance | |||||
---|---|---|---|---|---|---|---|
No (N = 46) | Yes (N = 59) | ||||||
N (%) | N (%) | Value | p-value | Sig. | |||
Oral mesalamine | No | 14 (30.43%) | 17 (28.81%) | 1.08 (0.47–2.51) | X2 = 0.033 | 0.857C | NS |
Yes | 32 (69.57%) | 42 (71.19%) | |||||
Topical mesalamine | No | 44 (95.65%) | 57 (96.61%) | 0.77 (0.11–5.7) | 1.00F | NS | |
Yes | 2 (4.35%) | 2 (3.39%) | |||||
Oral steroids | No | 28 (60.87%) | 41 (69.49%) | 0.68 (0.3–1.54) | X2 = 0.853 | 0.356C | NS |
Yes | 18 (39.13%) | 18 (30.51%) | |||||
Topical steroids | No | 44 (95.65%) | 59 (100%) | 0.19F | NS | ||
Yes | 2 (4.35%) | 0 (0%) | |||||
Azathioprine | No | 16 (34.78%) | 19 (32.2%) | 1.12 (0.5–2.54) | X2 = 0.077 | 0.781C | NS |
Yes | 30 (65.22%) | 40 (67.8%) | |||||
Biological therapy | No | 37 (80.43%) | 47 (79.66%) | 1.05 (0.4–2.76) | X2 = 0.01 | 0.922C | NS |
Yes | 9 (19.57%) | 12 (20.34%) | |||||
Type remicade 1–Humera 2 | No | 40 (86.96%) | 51 (86.44%) | 1.05 (0.34–3.26) | X2 = 0.006 | 0.939C | NS |
Yes | 6 (13.04%) | 8 (13.56%) | |||||
Surgical intervention | No | 43 (93.48%) | 55 (93.22%) | 1.04 (0.22–4.91) | 1.00F | NS | |
Yes | 3 (6.52%) | 4 (6.78%) | |||||
Did you stop TTT? | No | 40 (86.96%) | 54 (91.53%) | 0.62 (0.18–2.17) | 0.529F | NS | |
Yes | 6 (13.04%) | 5 (8.47%) |